Navigation Links
IGY Immune Technology & Life Sciences Purchases Manufacturing Facility to Produce Purified Immunoglobulin Y (IgY)
Date:4/30/2012

THUNDER BAY, Ontario, April 30, 2012 /PRNewswire/ -- IGY Immune Technology & Life Sciences has acquired manufacturing capabilities to produce its proprietary IgY products.  IgY from chicken egg yolks has long been recognized among scientists for its immune enhancing benefits in humans as well as its ability to deliver customized antibodies to fight sickness and maintain good health.  Until now, a consistent, purified source has not been available commercially.  IGY Immune Technology & Life Sciences expects to be producing IgY by the end of 2012.

"The acquisition of this facility and our existing intellectual property position make IGY Immune Technology the world's leader in the production of IgY," said Terry Dyck, chief executive officer. "The production of IgY at higher purity levels and lower cost will create a number of product development opportunities across the nutrition, cosmetic, pharmaceutical and animal health industries."

The existing world supply of IgY is very limited and expensive.  IGY Immune Technology's unique process is able to produce commercial quantities of IgY from chicken egg yolk.  The manufacturing facility is in close proximity to major egg producers and the production process utilizes no toxic chemicals allowing the egg yolk to be returned back into the food supply.

IGY Immune Technology & Life Sciences is already in the commercialization process with its first product and has a number of business partnerships in development with major life sciences corporations.  An opportunity for investment in IGY Immune Technology is also available.

"We're establishing ourselves already with leading companies that have been following IgY developments," said Dyck.  "We're moving forward in securing these partnerships as well as providing a profitable opportunity for investors."

For more information about IGY Immune Technology & Life Sciences, visit its web site at: http://www.igylifesciences.com


'/>"/>
SOURCE IGY Immune Technology & Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
2. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
3. MU researchers identify key plant immune response in fight against bacteria
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
6. Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration
7. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
8. Alcohol-related behavior changes -- blame your immune system
9. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
10. New HIV vaccine approach targets desirable immune cells
11. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... American ... two additional patents, U.S. Patent Nos. 9,322,133 and 9,322,134, to API and its ... nanocellulose as well as hydrophobic nanocellulose compositions. In addition to these patents ...
(Date:5/5/2016)... BELL, Pa. , May 5, 2016  Why ... Powers and Lorna Weir launching a ... un-agency way? Because they believe that truly helping clients ... world of healthcare now demands a different type of ... strategy lab serving the pharmaceutical, biotechnology and medical device ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... previously announced identification of its first three targets, it has identified a fourth ... beta (Aß), implicated in the development and progression of Alzheimer’s disease (AD). ...
(Date:5/4/2016)... ... 2016 , ... CereScan, the nation’s leader in providing statistically ... Stroke Awareness Month in May. An infographic created by CereScan will be ... will donate $1 up to a maximum of $3,000 through users who share ...
Breaking Biology Technology:
(Date:3/11/2016)... -- http://www.apimages.com ) - --> http://www.apimages.com ) ... AP Images ( http://www.apimages.com ) - Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ... Hanover next week.   --> Germany ... produce the new refugee identity cards. DERMALOG will be unveiling this ...
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/3/2016)... 2016  FlexTech, a SEMI Strategic Association Partner, awarded ... & Development, Leadership in Education, and, in a category ... th year of the FLEXI Awards and the ... from past years . Judging was done on ... of criteria, by a panel of non-affiliated, independent, industry ...
Breaking Biology News(10 mins):